| For: | Wang XS, Wang Y, Xu Y, Zhang SR, Zhang Y, Peng LL, Wu N, Ye JS. Effectiveness of mesenchymal stem cell-derived extracellular vesicles therapy for Parkinson’s disease: A systematic review of preclinical studies. World J Stem Cells 2025; 17(4): 102421 [PMID: 40308882 DOI: 10.4252/wjsc.v17.i4.102421] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v17/i4/102421.htm |
| Number | Citing Articles |
| 1 |
Gunjan Bawne, Magdalena J. Lorenowicz. Therapeutic mechanistic framework of mesenchymal stem cell-derived extracellular vesicles in neurodegenerative diseases. Extracellular Vesicles and Circulating Nucleic Acids 2026; 7(3) doi: 10.20517/evcna.2026.54
|
| 2 |
Barathan Muttiah, Nur Atiqah Haizum Abdullah. From Bench to Brain: Translating EV and Nanocarrier Research into Parkinson’s Disease Therapies. Biology 2025; 14(10) doi: 10.3390/biology14101349
|
| 3 |
Cézar Augusto Alves de Oliveira, Bernardo Scaldini Oliveira, Amanda Scaldini Oliveira, Rafael Duarte de Souza Loduca, Carlos Roberto Massella Junior, Gabriel Silva Santos. Orthobiologics and Peptide Therapy for Central Nervous System Repair in Neurodegenerative Conditions. Cells 2025; 14(23) doi: 10.3390/cells14231853
|
| 4 |
Casta馿yra-Perdomo Agust韓, Gonz醠ez-Mora Jos�Luis, Ilmoniemi Risto, Makris Nikos, Pallanti Stefano. The Relevance of Neurocircuitry-Based TMS EEG Biomarkers and EVs in Next Generation Versatile Therapeutic Approaches of the Human Glymphatic System: A Hypothesis-Driven Perspective. Immune Discovery 2026; 2(3) doi: 10.70322/immune.2026.10006
|